{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-107295","form_type":"8-K","ticker":"GUTS","cik":"0001572616","company_name":"FRACTYL HEALTH, INC.","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.392836+00:00","generated_at":"2026-05-17T14:35:18.924043+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fractyl Health Q2 2025 net loss $27.9M; $23M offering extends cash runway into 2026","bullets":["Net loss for Q2 2025 was $27.9 million, compared to $17.2 million in Q2 2024, driven by higher R&D spending and non-cash changes.","Completed $23 million underwritten public offering in August 2025, with potential additional $46 million from warrants.","Cash and cash equivalents were $22.3 million as of June 30, 2025; post-offering cash runway extends into 2026.","Positive 3-month REVEAL-1 Cohort data: 12 of 13 participants maintained weight after GLP-1 discontinuation with Revita.","Enrollment completed for REMAIN-1 Midpoint Cohort (45 participants); 3-month randomized data expected September 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-107295","json":"https://secwatch.observer/filing/0000950170-25-107295.json","markdown":"https://secwatch.observer/filing/0000950170-25-107295.md","text":"https://secwatch.observer/filing/0000950170-25-107295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1572616/000095017025107295/0000950170-25-107295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1572616/000095017025107295/guts-20250812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T14:35:18.924043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}